197 related articles for article (PubMed ID: 21570258)
1. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
Bhengraj AR; Srivastava P; Mittal A
Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
[No Abstract] [Full Text] [Related]
2. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
Jensen JS; Bradshaw CS; Tabrizi SN; Fairley CK; Hamasuna R
Clin Infect Dis; 2008 Dec; 47(12):1546-53. PubMed ID: 18990060
[TBL] [Abstract][Full Text] [Related]
4. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.
Zhu H; Wang HP; Jiang Y; Hou SP; Liu YJ; Liu QZ
Andrologia; 2010 Aug; 42(4):274-80. PubMed ID: 20629652
[TBL] [Abstract][Full Text] [Related]
5. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.
Misyurina OY; Chipitsyna EV; Finashutina YP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1347-9. PubMed ID: 15047540
[TBL] [Abstract][Full Text] [Related]
6. Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.
Riska PF; Kutlin A; Ajiboye P; Cua A; Roblin PM; Hammerschlag MR
Antimicrob Agents Chemother; 2004 Sep; 48(9):3586-90. PubMed ID: 15328134
[TBL] [Abstract][Full Text] [Related]
7. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
[TBL] [Abstract][Full Text] [Related]
8. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
[TBL] [Abstract][Full Text] [Related]
9. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.
Mendes RE; Deshpande LM; Farrell DJ; Spanu T; Fadda G; Jones RN
J Antimicrob Chemother; 2010 Nov; 65(11):2329-35. PubMed ID: 20841419
[TBL] [Abstract][Full Text] [Related]
10. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
[TBL] [Abstract][Full Text] [Related]
11. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
[TBL] [Abstract][Full Text] [Related]
12. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I.
Gestin B; Valade E; Thibault F; Schneider D; Maurin M
J Antimicrob Chemother; 2010 Nov; 65(11):2359-67. PubMed ID: 20837574
[TBL] [Abstract][Full Text] [Related]
14. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
[TBL] [Abstract][Full Text] [Related]
15. Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region.
Wu A; Buono S; Katz KA; Pandori MW
Microb Drug Resist; 2011 Sep; 17(3):425-7. PubMed ID: 21492017
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Renibacterium salmoninarum with reduced susceptibility to macrolide antibiotics by a standardized antibiotic susceptibility test.
Rhodes LD; Nguyen OT; Deinhard RK; White TM; Harrell LW; Roberts MC
Dis Aquat Organ; 2008 Aug; 80(3):173-80. PubMed ID: 18814542
[TBL] [Abstract][Full Text] [Related]
18. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene.
Jensen JS
Methods Mol Biol; 2012; 903():129-39. PubMed ID: 22782815
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
[TBL] [Abstract][Full Text] [Related]
20. An in vitro model of azithromycin-induced persistent Chlamydia trachomatis infection.
Xue Y; Zheng H; Mai Z; Qin X; Chen W; Huang T; Chen D; Zheng L
FEMS Microbiol Lett; 2017 Aug; 364(14):. PubMed ID: 28854672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
